No significant difference was observed in MVD in HM-1 tumor tissues on Day 8 between the anti-PD-L1 antibody treatment and the control treatment groups, and a significantly lower MVD was observed for the anti-VEGF antibody treatment both with and without anti-PD-L1 treatment compared with the control treatment. The gene discussed is VEGFA; the disease is neoplasm.